Studies

  1. Gut mucosal virome alterations in ulcerative colitis

  2. Fusobacterium nucleatum facilitates ulcerative colitis through activating IL-17F signaling to NF-κB via the upregulation of CARD3 expression

  3. Gut microbiome structure and metabolic activity in inflammatory bowel disease

  4. The gut microbiota heterogeneity and assembly changes associated with the IBD

  5. Growth effects of *N*-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease

  6. Gastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case-Control Study

  7. Differential prevalence of pathobionts and host gene polymorphisms in chronic inflammatory intestinal diseases: Crohn’s disease and intestinal tuberculosis

  8. Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis

  9. Association Between *Helicobacter pylori* Colonization and Inflammatory Bowel Disease. A Systematic Review and Meta-Analysis

  10. The Relationship Between *Helicobacter pylori* and Inflammatory Bowel Disease